Menu Search
Equities

Medibank Private Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
MPV:FRA

Medibank Private Ltd

Actions
  • Price (EUR)2.84
  • Today's Change0.18 / 6.77%
  • Shares traded--
  • 1 Year change+19.33%
  • Beta0.1891
Data delayed at least 15 minutes, as of Feb 18 2026 07:37 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year Medibank Private Ltd had little change in net income (from 492.50m to 500.80m) despite revenues that grew 4.61% from 7.80bn to 8.16bn.
Gross margin--
Net profit margin6.25%
Operating margin8.94%
Return on assets10.85%
Return on equity21.58%
Return on investment--
More ▼

Cash flow in AUDView more

In 2025, cash reserves at Medibank Private Ltd fell by 42.40m. However, the company earned 380.90m from its operations for a Cash Flow Margin of 4.67%. In addition the company generated 110.50m cash from investing, though they paid out 533.80m more in financing than they received.
Cash flow per share0.2198
Price/Cash flow per share20.57
Book value per share0.8482
Tangible book value per share0.6667
More ▼

Balance sheet in AUDView more

Medibank Private Ltd has a Debt to Total Capital ratio of 8.21%, a higher figure than the previous year's 6.58%.
Current ratio--
Quick ratio--
Total debt/total equity0.0895
Total debt/total capital0.0821
More ▼

Growth rates in AUD

SmartText is unavailable
Div yield(5 year avg)4.02%
Div growth rate (5 year)8.45%
Payout ratio (TTM)98.99%
EPS growth(5 years)9.67
EPS (TTM) vs
TTM 1 year ago		1.69
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.